CABA (-47%), AUTL (-30%), GRCL (-23%) are among the names selling off on today’s FDA press release.
Ouch that is quite a haircut. Sadly, my portfolio is familiar with such rapid drops. Such is the life of a biotech investor. In this case I am not a victim.